Research and development - Press Releases

Date	Title	Company
15-Jan-2025	Study shows connection between childhood maltreatment and disease in later life	University of Birmingham
15-Jan-2025	Oxford Drug Design achieves further in vivo validation of novel approach against multiple tumours	Oxford Drug Design
15-Jan-2025	Researchers uncover what drives aggressive bone cancer	Cell
14-Jan-2025	Tumour DNA in the blood can predict lung cancer outcome	Francis Crick Institute
14-Jan-2025	BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy	BioMed X Institute
14-Jan-2025	Novavax is Powering the Future of Vaccines Through R&D and Value-creating Business Strategy	Novavax
14-Jan-2025	BellaSeno Successfully Completes Two Clinical Trials with Novel, Resorbable Breast Implants	BellaSeno
10-Jan-2025	Aston University researchers seek participants for newly funded study into medication weight gain	Aston University
10-Jan-2025	New drug hope for prostate cancer patients	The Institute of Cancer Research
10-Jan-2025	CD Bioparticles Announces Enhanced Online Ordering System for Improved Customer Experience	CD Bioparticles
10-Jan-2025	CD Bioparticles Introduces Endotoxin Free Silver Nanoparticles for Advanced Biomedical Research	CD Bioparticles
10-Jan-2025	STEMart Announces Balloon Catheter Testing Services to Ensure Medical Device Safety and Regulatory Compliance	STEMart
10-Jan-2025	Creative Diagnostics Announces Enhanced Viral Nucleic Acid Residue Assay Kits for Biopharmaceutical Manufacturing	Creative Diagnostics
10-Jan-2025	Creative Diagnostics Introduces New Line of Diacetoxyscirpenol Test Reagents	Creative Diagnostics
10-Jan-2025	Creative Diagnostics Advances Zika Virus Research with Novel Animal Models	Creative Diagnostics
10-Jan-2025	Creative Diagnostics Launches High-Performance HPV IgG ELISA Kit for Accurate and Reliable HPV Antibody Detection	Creative Diagnostics
09-Jan-2025	Lung cancer test predicts survival in early stages better than current methods	Francis Crick Institute
09-Jan-2025	ICR welcomes NICE recommendation of olaparib for advanced breast cancer	ICR
09-Jan-2025	Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines	Coave Therapeutics
09-Jan-2025	Breakthrough Gene Editing Technique Offers Hope for Stargardt Disease Patients	Institute of Molecular and Clinical Ophthalmology Basel (IOB)